Deutsche Bank Ag\ Savara Inc Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Savara Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 874,541 shares of SVRA stock, worth $2.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

874,541

Previous 782,098 11.82%

Holding current value

$2.94 Million

Previous $3.15 Million 17.68%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.96 - $5.07 $366,074 - $468,686	92,443 Added 11.82%	874,541 $3.71 Million
Q2 2024 Aug 14, 2024	BUY	$3.66 - $5.34 $103,259 - $150,657	28,213 Added 3.74%	782,098 $3.15 Million
Q1 2024 May 15, 2024	BUY	$4.19 - $5.59 $3.02 Million - $4.03 Million	720,720 Added 2173.13%	753,885 $3.75 Million
Q4 2023 Feb 14, 2024	BUY	$3.18 - $4.9 $39,365 - $60,657	12,379 Added 59.55%	33,165 $155,000
Q3 2023 Nov 09, 2023	BUY	$2.97 - $3.88 $61,734 - $80,649	20,786 New	20,786 $78,000
Q2 2021 Aug 11, 2021	SELL	$1.51 - $2.29 $45,885 - $69,588	-30,388 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$1.17 - $2.33 $3,422 - $6,815	-2,925 Reduced 8.78%	30,388 $63,000
Q4 2020 Feb 16, 2021	BUY	$1.0 - $1.47 $9,710 - $14,273	9,710 Added 41.14%	33,313 $38,000
Q3 2020 Nov 12, 2020	BUY	$1.09 - $2.21 $1,345 - $2,727	1,234 Added 5.52%	23,603 $26,000
Q2 2020 Aug 13, 2020	BUY	$1.8 - $3.05 $19,272 - $32,656	10,707 Added 91.81%	22,369 $55,000
Q1 2020 May 14, 2020	SELL	$1.91 - $4.08 $56,356 - $120,384	-29,506 Reduced 71.67%	11,662 $25,000
Q4 2019 Feb 14, 2020	BUY	$0.71 - $4.91 $22,419 - $155,043	31,577 Added 329.24%	41,168 $183,000
Q3 2019 Nov 14, 2019	BUY	$2.16 - $3.2 $220 - $326	102 Added 1.07%	9,591 $25,000
Q2 2019 Aug 14, 2019	SELL	$2.37 - $11.7 $208,095 - $1.03 Million	-87,804 Reduced 90.25%	9,489 $20,000
Q1 2019 May 15, 2019	BUY	$6.71 - $8.6 $424,139 - $543,606	63,210 Added 185.46%	97,293 $715,000
Q4 2018 Feb 14, 2019	SELL	$6.27 - $10.92 $235,231 - $409,685	-37,517 Reduced 52.4%	34,083 $257,000
Q3 2018 Dec 21, 2021	BUY	$10.49 - $12.87 $131,974 - $161,917	12,581 Added 21.32%	71,600 $799,000
Q3 2018 Nov 14, 2018	BUY	$10.49 - $12.87 $26,424 - $32,419	2,519 Added 4.46%	59,019 $657,000
Q2 2018 Apr 21, 2020	BUY	$8.55 - $13.76 $103,036 - $165,821	12,051 Added 27.11%	56,500 $640,000
Q2 2018 Aug 14, 2018	SELL	$8.55 - $13.76 $633,426 - $1.02 Million	-74,085 Reduced 62.5%	44,449 $502,000
Q1 2018 Oct 18, 2019	BUY	$8.99 - $14.95 $33,137 - $55,105	3,686 Added 3.21%	118,534 $1.09 Million
Q1 2018 May 15, 2018	BUY	$8.99 - $14.95 $872,794 - $1.45 Million	97,085 Added 546.56%	114,848 $1.06 Million
Q4 2017 Feb 14, 2018	BUY	$8.26 - $16.76 $146,615 - $297,490	17,750 Added 136538.45%	17,763 $263,000
Q3 2017 Nov 14, 2017	BUY	$5.1 - $9.55 $66 - $124	13	13 $0

Others Institutions Holding SVRA

# of Institutions

129

Shares Held

158M

Call Options Held

67.6K

Put Options Held

29.4K

View Full List

About Savara Inc

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $383M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

More about SVRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account